Pharmacological and non-pharmacological treatments in amyotrophic lateral sclerosis: an Italian real-world data study.

Autor: Paoletti O; Pharmacoepidemiology Unit, Regional Health Agency of Tuscany, Florence, Italy., Hyeraci G; Pharmacoepidemiology Unit, Regional Health Agency of Tuscany, Florence, Italy., Finochietti M; Department of Epidemiology, ASL Roma 1, SSR Lazio, Rome, Italy., Celani MG; Neurophysiopathology, Perugia Hospital, Perugia, Italy., Bacigalupo I; National Center for Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy., Lombardi N; Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.; Tuscan Regional Centre of Pharmacovigilance, Florence, Italy., Crescioli G; Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.; Tuscan Regional Centre of Pharmacovigilance, Florence, Italy., Tuccori M; Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Cascini S; Department of Epidemiology, ASL Roma 1, SSR Lazio, Rome, Italy., Gini R; Pharmacoepidemiology Unit, Regional Health Agency of Tuscany, Florence, Italy., Addis A; Department of Epidemiology, ASL Roma 1, SSR Lazio, Rome, Italy., Kirchmayer U; Department of Epidemiology, ASL Roma 1, SSR Lazio, Rome, Italy.

Publikováno v: European journal of neurology [Eur J Neurol] 2024 Dec; Vol. 31 (12), pp. e16470. Date of Electronic Publication: 2024 Sep 19.

Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis.

Autor: Durán CE; Julius Center for Health Sciences and Primary Care, Department of Data Science and Biostatistics, University Medical Center Utrecht, Utrecht, Netherlands., Riera-Arnau J; Julius Center for Health Sciences and Primary Care, Department of Data Science and Biostatistics, University Medical Center Utrecht, Utrecht, Netherlands.; Department of Clinical Pharmacology, Vall Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Abtahi S; Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, Netherlands., Pajouheshnia R; Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, Netherlands., Hoxhaj V; Julius Center for Health Sciences and Primary Care, Department of Data Science and Biostatistics, University Medical Center Utrecht, Utrecht, Netherlands., Gamba M; Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, Netherlands., Alsina E; Julius Center for Health Sciences and Primary Care, Department of Data Science and Biostatistics, University Medical Center Utrecht, Utrecht, Netherlands., Martin-Perez M; Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain., Garcia-Poza P; Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain., Llorente-Garcia A; Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain., Gonzalez-Bermejo D; Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain., Ibánez L; Department of Clinical Pharmacology, Vall Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Sabaté M; Department of Clinical Pharmacology, Vall Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Vidal X; Department of Clinical Pharmacology, Vall Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Ballarín E; Department of Clinical Pharmacology, Vall Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Sanfélix-Gimeno G; The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Health Services Research Unit (FISABIO - HSRU), Valencia, Spain., Rodríguez-Bernal C; The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Health Services Research Unit (FISABIO - HSRU), Valencia, Spain., Peiró S; The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Health Services Research Unit (FISABIO - HSRU), Valencia, Spain., García-Sempere A; The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Health Services Research Unit (FISABIO - HSRU), Valencia, Spain., Sanchez-Saez F; The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Health Services Research Unit (FISABIO - HSRU), Valencia, Spain., Ientile V; Department of Biomedical and Dental Sciences and Morpho-functional Imaging, University of Messina, Messina, Italy., Ingrasciotta Y; Section of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Guarneri C; Department of Biomedical and Dental Sciences and Morpho-functional Imaging, University of Messina, Messina, Italy., Tanaglia M; Section of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Tari M; Caserta Local Health Unit, Caserta, Italy., Herings R; PHARMO Institute, Utrecht, Netherlands., Houben E; PHARMO Institute, Utrecht, Netherlands., Swart-Polinder K; PHARMO Institute, Utrecht, Netherlands., Holthuis E; PHARMO Institute, Utrecht, Netherlands., Huerta C; Department of Public Health and Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain., Gini R; Agenzia Regionale di Sanità Della Toscana (ARS), Florence, Italy., Roberto G; Agenzia Regionale di Sanità Della Toscana (ARS), Florence, Italy., Bartolini C; Agenzia Regionale di Sanità Della Toscana (ARS), Florence, Italy., Paoletti O; Agenzia Regionale di Sanità Della Toscana (ARS), Florence, Italy., Limoncella G; Agenzia Regionale di Sanità Della Toscana (ARS), Florence, Italy., Girardi A; Agenzia Regionale di Sanità Della Toscana (ARS), Florence, Italy., Hyeraci G; Agenzia Regionale di Sanità Della Toscana (ARS), Florence, Italy., Andersen M; Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Kristiansen SB; Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Hallgreen CE; Copenhagen Centre for Regulatory Science, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Klungel O; Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, Netherlands., Sturkenboom M; Julius Center for Health Sciences and Primary Care, Department of Data Science and Biostatistics, University Medical Center Utrecht, Utrecht, Netherlands.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2023 Aug 17; Vol. 14, pp. 1207976. Date of Electronic Publication: 2023 Aug 17 (Print Publication: 2023).

Cases of acquired hemophilia A following COVID-19 vaccines: Cogent safety signal or possible reporting/detection bias? Preliminary evidence from Tuscany, Italy.

Autor: Roberto G; Epidemiology unit, Agenzia Regionale di Sanità della Toscana, Florence, Italy., Paoletti O; Epidemiology unit, Agenzia Regionale di Sanità della Toscana, Florence, Italy., Ferraro S; Department of Clinical and Experimental Medicines, Pharmacovigilance Unit, University of Pisa, Pisa, Italy., Hyeraci G; Epidemiology unit, Agenzia Regionale di Sanità della Toscana, Florence, Italy., Franchini M; Division of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy., Gini R; Epidemiology unit, Agenzia Regionale di Sanità della Toscana, Florence, Italy., Focosi D; University Hospital of Pisa, Blood Bank of Tuscany, North-West Local Health Unit, Pisa, Italy., Tuccori M; Department of Clinical and Experimental Medicines, Pharmacovigilance Unit, University of Pisa, Pisa, Italy.

Publikováno v: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2023 Jun; Vol. 32 (6), pp. 694-699. Date of Electronic Publication: 2023 Mar 27.

A systematic review of case-identification algorithms based on italian healthcare administrative databases for three relevant diseases of the cardiovascular system: Acute myocardial infarction, ischemic heart disease, and stroke

Autor: Hyeraci, G., Spini, A., Roberto, G., Gini, R., Bartolini, C., Lucenteforte, E., Corrao, G., Rea, F.

BACKGROUND: acute myocardial infarction (AMI), ischemic heart diseases (IHDs) and stroke are serious cardiovascular diseases (CVDs) which may lead to hospitalizations, require periodical medical monitoring and life-long drugs use, thus having a high

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ea7611ebc3ca31af0a0232e80a274b1b
http://hdl.handle.net/10281/272248

Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany.

Autor: Hyeraci G; Agenzia regionale di sanità della Toscana (ARS), Florence, Italy., Gini R; Agenzia regionale di sanità della Toscana (ARS), Florence, Italy., Bezin J; Clinical Pharmacology Unit, Univ. Bordeaux, INSERM, BPH, Team Pharmacoepidemiology, U1219, CHU de Bordeaux, Bordeaux, France., Iannone LF; Headache Centre, Careggi University Hospital, Department of Health Sciences, University of Florence, Florence, Italy., Benemei S; Headache Centre, Careggi University Hospital, Department of Health Sciences, University of Florence, Florence, Italy., Lupi C; Area Vasta Centro Ethics Committee Secretariat - Clinical Trial Unit for Phase 1 Trials, Careggi University Hospital, Florence, Italy., De Cesaris F; Headache Centre, Careggi University Hospital, Department of Health Sciences, University of Florence, Florence, Italy., Geppetti P; Headache Centre, Careggi University Hospital, Department of Health Sciences, University of Florence, Florence, Italy., Roberto G; Agenzia regionale di sanità della Toscana (ARS), Florence, Italy.

Publikováno v: Headache [Headache] 2023 Feb; Vol. 63 (2), pp. 222-232. Date of Electronic Publication: 2023 Jan 27.